Health In Tech, Inc. (HIT) Form 424B3 — Oct 19, 2026
Health In Tech filed a 424B3 prospectus registering the resale by Yorkville of up to 34,224,247 Class A shares issuable under an August 2026 Standby Equity Purchase Agreement, comprising up to 9,532,889 conversion shares from up to $15 million of convertible notes and 24,691,358 advance shares tied to a $20 million purchase commitment. If all registered shares were issued, they would represent roughly 39% of the 53,600,790 shares outstanding and about 62.3% of the non-affiliate float. The notes carry 8.75% interest (18% on default), a $1.5735 fixed conversion price with price-protection anti-dilution, and monthly installments with a 4% payment premium through a February 18, 2028 maturity.
Key figures
- Debt Amount
- 15000000
- Interest Rate
- 8.75
- Maturity Date
- 2028-02-18
- Gross Proceeds
- 35000000
- Shares Offered
- 34224247
- Shares Outstanding
- 53600790
- Advance shares
- 24691358
- Commitment fee
- 200000
- Iib success fee
- 6.5% of gross principal
- Payment premium
- 4%
- Structuring fee
- 25000
- Commitment amount
- $20.0 million
- Conversion shares
- 9532889
- First tranche net
- 6650000
- Second tranche net
- 2850000
- Exchange cap shares
- 13100378
- First note principal
- 7000000
- Assumed advance price
- 0.81
- Default interest rate
- 18
- Fixed conversion price
- 1.5735
- Closing price oct16 2026
- 0.65
- Beneficial ownership limit
- 4.99%
- Dilution pct of outstanding
- 39.0%
- Dilution pct of non affiliate
- 62.3%
- Shares out after full issuance
- 87825037
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.